JPH0527616B2 - - Google Patents

Info

Publication number
JPH0527616B2
JPH0527616B2 JP59087964A JP8796484A JPH0527616B2 JP H0527616 B2 JPH0527616 B2 JP H0527616B2 JP 59087964 A JP59087964 A JP 59087964A JP 8796484 A JP8796484 A JP 8796484A JP H0527616 B2 JPH0527616 B2 JP H0527616B2
Authority
JP
Japan
Prior art keywords
bis
dimethylamino
formula
acid addition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59087964A
Other languages
English (en)
Japanese (ja)
Other versions
JPS606646A (ja
Inventor
Je Najii Imure
Emuri Jujanna
Yancho Saandoru
Cherunusu Isutobaan
Baarinto Yaanosu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Biogal Gyogyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar Rt filed Critical Biogal Gyogyszergyar Rt
Publication of JPS606646A publication Critical patent/JPS606646A/ja
Publication of JPH0527616B2 publication Critical patent/JPH0527616B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Devices For Use In Laboratory Experiments (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP59087964A 1983-05-02 1984-05-02 1,3−ビス(ジメチルアミノ)−2−プロピル−4−クロロフエノキシアセテ−ト,その製法及び医薬組成物 Granted JPS606646A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU2251-1496/83 1983-05-02
HU831496A HU190589B (en) 1983-05-02 1983-05-02 Process for preparing acid additional salts of 4-chloro-phenoxy-acetic acid-1,3-bis/dimethyl-amino/-2-propyl-ester

Publications (2)

Publication Number Publication Date
JPS606646A JPS606646A (ja) 1985-01-14
JPH0527616B2 true JPH0527616B2 (cs) 1993-04-21

Family

ID=10954727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59087964A Granted JPS606646A (ja) 1983-05-02 1984-05-02 1,3−ビス(ジメチルアミノ)−2−プロピル−4−クロロフエノキシアセテ−ト,その製法及び医薬組成物

Country Status (20)

Country Link
US (1) US4661618A (cs)
EP (1) EP0127000B1 (cs)
JP (1) JPS606646A (cs)
KR (1) KR840009292A (cs)
AT (1) ATE24712T1 (cs)
AU (1) AU565723B2 (cs)
BG (1) BG42833A3 (cs)
CA (1) CA1246602A (cs)
CS (1) CS241081B2 (cs)
DD (1) DD216449A5 (cs)
DE (1) DE3461924D1 (cs)
DK (1) DK214884A (cs)
EG (1) EG16744A (cs)
ES (1) ES8506259A1 (cs)
FI (1) FI81562C (cs)
HU (1) HU190589B (cs)
IL (1) IL71714A (cs)
NZ (1) NZ208011A (cs)
PL (1) PL142906B1 (cs)
SU (2) SU1376937A3 (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546273A (en) * 1967-06-01 1970-12-08 Merck & Co Inc Ester derivatives of 2-(4-halophenoxy)alkanoic acids
JPS5135896B2 (cs) * 1973-06-20 1976-10-05

Also Published As

Publication number Publication date
PL247504A1 (en) 1985-03-26
EG16744A (en) 1990-12-30
EP0127000B1 (de) 1987-01-07
ES532062A0 (es) 1985-07-01
CS321784A2 (en) 1985-06-13
ATE24712T1 (de) 1987-01-15
DK214884D0 (da) 1984-04-27
AU565723B2 (en) 1987-09-24
NZ208011A (en) 1987-06-30
CS241081B2 (en) 1986-03-13
FI841611A0 (fi) 1984-04-24
KR840009292A (ko) 1984-12-26
FI841611A (fi) 1984-11-03
PL142906B1 (en) 1987-12-31
DK214884A (da) 1984-11-03
HUT34150A (en) 1985-02-28
US4661618A (en) 1987-04-28
SU1326572A1 (ru) 1987-07-30
CA1246602A (en) 1988-12-13
DD216449A5 (de) 1984-12-12
FI81562B (fi) 1990-07-31
ES8506259A1 (es) 1985-07-01
IL71714A (en) 1987-09-16
JPS606646A (ja) 1985-01-14
DE3461924D1 (en) 1987-02-12
BG42833A3 (en) 1988-02-15
EP0127000A1 (de) 1984-12-05
AU2761084A (en) 1984-11-08
IL71714A0 (en) 1984-09-30
SU1376937A3 (ru) 1988-02-23
FI81562C (fi) 1990-11-12
HU190589B (en) 1986-09-29

Similar Documents

Publication Publication Date Title
DE60008372T2 (de) Pharmazeutisch aktive verbindungen
AU652951B2 (en) Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions
AU613890B2 (en) 4-thiazolidinecarboxylic acid derivative, its preparation and pharmaceutical compositions containing it
WO2005028476A1 (fr) Derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant
EP0161599A2 (de) Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0001115A2 (de) 2-Bromergosin und seine Säureadditionssalze, Verfahren zu deren Herstellung sowie deren Verwendung als Heilmittel
EP0316279A2 (de) Veresterte azacyclische Hydroxyverbindungen
WO1997026242A1 (fr) Derives de 3-(bis-phenylmethylene substitue) oxindole
CA2141366A1 (en) Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds
DE69822937T2 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
WO1995018817A1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
US5834495A (en) Crystalline xamoneline tartrate
US4851414A (en) Anti-dementia agent
FR2553663A1 (fr) Derives du 1,2-dithiolanne, leur preparation et leur utilisation comme medicaments
JPH0527616B2 (cs)
DE69910787T2 (de) Neuartige, pharmazeutisch aktive verbindung
JPS62108863A (ja) 2−ピリジル酢酸誘導体、その製法およびそれを含む医薬
EP0121856A2 (de) Verwendung von Pyrazolonderivaten bei der Bekämpfung des Wachstums von Tumorzellen und der Metastasenbildung, Arzneimittel hierfür und Verfahren zu deren Herstellung
CH628321A5 (en) Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives
JPS5920282A (ja) エブルナン−オキシムエ−テル、その製造方法および該化合物を含む医薬製剤
JPH11509188A (ja) プロドラッグ6−n−(l−ala−l−ala)トロバフロキサシンの多形体
WO1985005103A1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
WO2002008229A1 (fr) DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO [4,5-β] INDOLE-1-CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
JPS63170383A (ja) 脂環式ジカルボン酸イミド化合物
JPH04173790A (ja) ヒダントイン誘導体並びにそれを有効成分とする糖尿病合併症及び循環器系疾患の予防及び治療剤